,

Yoh-Ichiro Iwasa1, Tomoyuki Nakajima2, Kentaro Hori1

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Biomolecules
|December 23, 2023
PubMed
概括

在头角状细胞癌 (HNSCC) 中对抗编程死亡-1 (PD-1) 治疗的获得性耐药性涉及动态瘤和微环境变化. 瘤中的表观遗传修饰似乎阻碍了抗PD-1免疫反应.